How Many Years of Life Do Female Smokers Lose on Average?

Female smokers lose roughly ten to twelve years of life expectancy compared to women who never smoked, according to large contemporary studies in Western populations. That figure is not a single fixed number, though. It shifts depending on when a woman started smoking, how heavily she smoked, where she lived, and which birth cohort she belonged to. Some studies peg the loss closer to four years, others closer to twelve, and the reasons for those differences tell a revealing story about how the smoking epidemic hit women later and harder than many people realize.

Where the Main Estimates Come From

The wide range in published estimates is not a sign that the science is confused. It reflects real differences between populations and time periods. A large pooled analysis of U.S., U.K., and other high-income data found that women who continued smoking lost about 12 years of survival between the ages of 40 and 79 compared to women who never smoked. That estimate blends together smokers who died from their habit and smokers who did not, averaging out to roughly 24 to 26 years lost among those who actually died from smoking-related causes and zero years lost for those who got lucky.¹

A Japanese prospective study found a loss of about ten years for women who began smoking before age 20. Among those women, born between 1920 and 1945, roughly 79 percent survived to age 70. Among women of the same generation who never smoked, the same 79 percent threshold was not reached until age 80.² A separate large-scale Japanese cohort analysis, however, found a more modest loss of about 3.6 years for female smokers at age 40 compared to never-smokers.³ That smaller number reflects a population where women historically smoked fewer cigarettes per day and adopted the habit later than Western women did.

A Danish study provided one of the starkest findings for dose: among women smoking about 15 to 20 grams of tobacco daily, the reduction in life expectancy was 9.4 years compared to never-smokers. In the same study, men at the same consumption level lost 8.4 years, meaning women actually fared worse.⁴ The overall picture is that in populations where women smoked at rates and intensities approaching those of men, the life-years lost climb into the range of a full decade.

The Gender Gap Has Closed, and That Is Bad News

For decades, smoking killed far more men than women, simply because men started smoking earlier in the twentieth century and smoked more heavily. As women’s smoking rates caught up, so did their death rates. A landmark U.S. analysis tracking 50 years of trends found that by the most recent cohorts, the relative risk of death from smoking was nearly identical for both sexes. Female current smokers faced about 2.76 times the all-cause death rate of never-smokers, compared to 2.80 for men.⁵ The same study found that the relative risks for specific killers like chronic obstructive pulmonary disease (COPD), heart disease, and stroke were also converging between the sexes.

This convergence has been confirmed across high-income countries broadly. An analysis of 17 countries found that more recent birth cohorts showed shrinking differences between male and female smoking-related mortality.⁶ In a separate U.S. cohort, the hazard ratio for death among female current smokers aged 25 to 79 was actually 3.0, slightly higher than the 2.8 found in men.⁷ If anything, women in recent generations face the same or marginally higher risk as male smokers, not the lower risk that older data once suggested.

What Kills Female Smokers

The diseases that drive these lost years are not abstract risks. For women who never smoke, breast cancer and heart disease carry similar ten-year mortality risks until around age 60, when heart disease pulls ahead as the leading killer. But for women who smoke, the picture shifts dramatically: the chance of dying from heart disease or lung cancer exceeds the chance of dying from breast cancer starting at age 40 and outpaces it by at least five-fold after age 55.⁸ That reordering of risk is worth pausing on. Breast cancer understandably gets enormous attention in women’s health. But for a woman who smokes, lung cancer and cardiovascular disease are the bigger statistical threats from middle age onward.

The 50-year U.S. trend data reinforce this: the relative risk of dying from COPD for female smokers was 22.35 compared to never-smokers, and for ischemic heart disease it was 2.86. These are now in the same range as the male figures.⁵ COPD in particular has become a growing concern for women, with research suggesting that women may develop earlier and more severe forms of the disease for the same amount of smoking.⁹

Biological Vulnerabilities Specific to Women

There is a growing body of evidence that female smokers are not just catching up to male smokers in exposure but may be biologically more susceptible to certain types of harm. Research on cigarette smoke metabolism has pointed to sex differences in how the lungs process tobacco chemicals, and the burden of both COPD and lung cancer in women has been rising faster than changes in smoking habits alone would explain.¹⁰

Smoking also disrupts the hormonal environment in ways that matter specifically for women. Epidemiological evidence indicates that women who smoke are effectively estrogen-deficient: they tend to reach natural menopause earlier and have altered estrogen metabolism. Smoking appears to shift how the body processes estradiol, favoring the production of inactive forms. This hormonal disruption carries downstream consequences including increased risk of osteoporotic fractures.¹¹ Earlier menopause alone would not account for the magnitude of life-years lost, but it contributes to a cascade of health effects that compound over the remaining decades of life.

The Oral Contraceptive Amplifier

One of the most clinically important interactions for younger women is the combination of smoking with oral contraceptive use. Cardiovascular disease risk is amplified when these two exposures overlap, and the amplification grows steeply with age. Among oral contraceptive users who smoked, hemorrhagic stroke and heart attacks together accounted for 80 percent of cardiovascular deaths in women aged 20 to 24 and 97 percent in women aged 40 to 44.¹² For women over 35 who smoke, the absolute risks associated with oral contraceptive use climb sharply because the underlying incidence of arterial diseases is already rising at that age.¹³

This is why prescribing guidelines strongly discourage combined oral contraceptives for women over 35 who smoke. The interaction is not just additive. The two risk factors compound each other in a way that produces outsized cardiovascular danger, particularly for stroke and heart attack.

How Quitting Changes the Math

The life-years-lost figure is not a permanent sentence. Women who quit smoking by age 35 gained roughly six to nearly eight additional years of life compared to women who kept smoking.¹⁴ That almost erases the deficit entirely. Even women who quit at 65 gained about three to nearly four years, a meaningful extension at any stage of life.¹⁴

The timeline of recovery depends on the disease. For vascular conditions, the benefits appear fast. A study of women’s mortality after quitting found that about 61 percent of the full potential benefit of quitting for coronary heart disease and 42 percent for stroke was realized within the first five years. Respiratory diseases take longer: it took roughly 20 years after quitting for the risk of death from respiratory causes to reach the level of a never-smoker. COPD followed a similar drawn-out timeline.¹⁵ So while the heart and blood vessels recover relatively quickly, the lungs carry the imprint of smoking for decades.

It Is Not Just About Dying Sooner

Framing the cost of smoking purely in years of life lost understates the problem. Researchers have developed a measure called quality-adjusted life expectancy that accounts for years lived with disability and reduced well-being, not just total lifespan. By this measure, an 18-year-old smoker in the United States could expect about 11 fewer quality-adjusted years of life compared to a nonsmoker of the same age. About 37 percent of that gap came from reductions in health-related quality of life rather than earlier death.¹⁶ In plain terms, smokers do not just die younger; they spend more of their remaining years dealing with chronic illness, pain, and functional limitations.

A Belgian study confirmed this pattern and added a gender nuance: while both male and female smokers experienced higher rates of disability than never-smokers, female smokers in particular faced a combination of shorter total life expectancy and shorter disability-free life expectancy. Their higher mortality actually “outweighed” their disability burden in statistical terms, meaning they died before spending as many years disabled as they otherwise might have. That is a grim kind of accounting.¹⁷

Secondhand Smoke and Women Who Do Not Smoke

A discussion of how smoking affects women’s longevity would be incomplete without mentioning secondhand smoke, which disproportionately affects women in many societies. A Japanese cohort study found that women who never smoked but were exposed to secondhand smoke had a 36 percent higher risk of death from all causes compared to never-smokers without that exposure.¹⁸ When secondhand smoke was factored in, the share of female deaths attributable to tobacco exposure jumped from about 2.3 percent to 8.4 percent. That is a nearly fourfold increase and suggests the conventional estimates of smoking’s toll on women undercount its true reach by ignoring passive exposure.

Pregnancy and Effects That Reach the Next Generation

For women of childbearing age, smoking carries risks that extend beyond their own lifespan. Maternal smoking during pregnancy is consistently linked to preterm birth, restricted fetal growth, low birth weight, and a higher risk of sudden infant death syndrome. The effects do not stop at birth: children exposed to tobacco smoke in utero face elevated rates of asthma, obesity, hypertension, type 2 diabetes, and neurodevelopmental problems later in life.¹⁹

Animal research suggests that nicotine itself, rather than any of the thousands of other chemicals in cigarette smoke, may be a key driver of many of these long-term effects in offspring, including impaired fertility, metabolic disorders, and respiratory dysfunction.²⁰ This is relevant for women using nicotine replacement therapy or e-cigarettes during pregnancy, since the assumption that removing combustion removes all fetal harm may not hold up.

Why Older Estimates Were Lower

If you come across older sources quoting much smaller life-expectancy losses for female smokers, sometimes in the range of three to four years, those numbers are not wrong. They reflect populations where women smoked less and started later in life. The Japanese pooled cohort, for instance, found a 3.6-year gap for women, partly because the average female smoker in those studies consumed far fewer cigarettes than Western counterparts.³ In that same population, Japanese women who started before age 20 and smoked more heavily lost a full decade.²

The lesson is that smoking’s toll scales with duration and intensity. A woman who smoked five cigarettes a day for ten years in her twenties and then quit faces a very different risk profile from a woman who smoked a pack a day from age 16 onward. The headline figure of roughly ten years lost applies most directly to sustained, moderate-to-heavy smoking over a lifetime. Light or short-duration smoking carries real but substantially smaller risks. That said, “light” smoking is not safe smoking, and even a few cigarettes a day carry measurable cardiovascular and cancer risk above baseline.

The European Population Picture

At the population level, smoking’s impact on women’s life expectancy across Europe remains significant even as smoking rates have declined. An analysis of 30 European countries estimated that eliminating smoking-attributable mortality among women would have added 0.77 years of life expectancy in 2014, up from 0.62 years in 1990. That increase during a period of declining smoking rates reflects the lag between when women in Europe took up the habit en masse and when the resulting deaths materialized decades later. Across all 30 countries, smoking, obesity, and alcohol together accounted for about 19 percent of female deaths.²¹ These are population-average numbers, meaning they dilute the toll experienced by individual smokers across all women including the majority who never smoked. For individual female smokers in Europe, the per-person losses remain in the range documented by the Danish and other cohort studies.

1
PubMed. Smoking Cessation and Short- and Longer-Term Mortality
2
BMJ. Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study
3
PubMed Central. Reduced Life Expectancy due to Smoking in Large-Scale Cohort Studies in Japan
4
PubMed Central. Life expectancy in Danish women and men related to smoking habits: smoking may affect women more
5
PubMed Central. 50-year trends in smoking-related mortality in the United States
6
PubMed Central. Progression of the smoking epidemic in high-income regions and its effects on male-female survival differences: a cohort-by-age analysis of 17 countries
7
PubMed. 21st-century hazards of smoking and benefits of cessation in the United States
8
PubMed Central. The Risk of Death by Age, Sex, and Smoking Status in the United States: Putting Health Risks in Context
9
PubMed. Vulnerability of women to tobacco: The broncho-pulmonary consequences
10
American Journal of Respiratory and Critical Care Medicine. The Growing Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer in Women: Examining Sex Differences in Cigarette Smoke Metabolism
11
American Journal of Obstetrics & Gynecology. Cigarette smoking and estrogen-related disease in women
12
Journal of Epidemiology & Community Health. Combined oral contraceptives, smoking, and cardiovascular risk
13
PubMed. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke
14
PubMed Central. Benefits of Smoking Cessation for Longevity
15
JAMA. Smoking and Smoking Cessation in Relation to Mortality in Women
16
PubMed Central. Quality-adjusted life expectancy (QALE) loss due to smoking in the United States
17
PubMed Central. The effect of smoking on the duration of life with and without disability, Belgium 1997-2011
18
BMJ. Has the impact of cigarette smoking on mortality been underestimated by overlooking second-hand smoke? Tohoku medical megabank community-based cohort study
19
PubMed Central. Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review
20
Toxicological Sciences. Long-Term Consequences of Fetal and Neonatal Nicotine Exposure: A Critical Review
21
Oxford Academic (International Journal of Epidemiology). The combined impact of smoking, obesity and alcohol on life-expectancy trends in Europe